Intranasal recombinant MVA-based vaccines effective against SARS-CoV-2 variants in mice - News-Medical.Net
Researchers construct a recombinant host-range restricted vaccinia virus Ankara (rMVAs) expressing the spike proteins of several SARS-CoV-2 variants.
In a recent study posted to the bioRxiv* preprint server, researchers construct a recombinant host-range restricted vaccinia virus Ankara (rMVAs) expressing the spike (S) proteins of several severe a… [+6314 chars]
Read More
Other Stories in Health
- Breakthrough discovery could lead to new class of antibiotics
- Cell's stress response is more nuanced and compartmentalized than previously thought
- Glutamate key to unlocking liver regeneration after acute damage
- Researchers trace 73% of US Salmonella cases to chicken and vegetables
- CDC confirms black-legged ticks can cause red meat allergy in humans
- Power Of Hydration: How Drinking Water Boosts Weight Loss And Improves Overall Health
- Study reveals gaps in lung cancer screening despite updated guidelines
- Cellular models of embryos offer insights into early developmental processes
- When genes wield a sickle
.png)
